Company intelligence / Profile preview

SYNformulas

Gräfelfing, Bavaria, Germanysynformulas.com ↗

Ownership: Private
Development stage: Commercial

Overview

SYNformulas has achieved clinical breakthroughs in the treatment of irritable bowel syndrome with its patented bacterial strain MIMBb75. This strain demonstrated significant efficacy in two independent studies and was included in the updated S3 guideline for IBS clinical practice. The company’s Kijimea® brand is a market leader for IBS medical devices and supplements, with clinically proven effectiveness

Therapeutic areas: GastroenterologyImmunology
Modalities: Live biotherapeutic product therapyMicrobial therapyMedical food (for some products)
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

Kijimea IBS PRO

Commercial

Indications: Irritable bowel syndrome

2 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with international universities and research networks for R&D

Beyond the preview

Go deeper on SYNformulas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SYNformulas.

Explore the full profile